251 related articles for article (PubMed ID: 23202505)
1. Arenaviruses and lethal mutagenesis. Prospects for new ribavirin-based interventions.
Moreno H; Grande-Pérez A; Domingo E; Martín V
Viruses; 2012 Nov; 4(11):2786-805. PubMed ID: 23202505
[TBL] [Abstract][Full Text] [Related]
2. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).
Ruiz-Jarabo CM; Ly C; Domingo E; de la Torre JC
Virology; 2003 Mar; 308(1):37-47. PubMed ID: 12706088
[TBL] [Abstract][Full Text] [Related]
3. Arenavirus extinction through lethal mutagenesis.
de la Torre JC
Virus Res; 2005 Feb; 107(2):207-14. PubMed ID: 15649566
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
de la Torre JC
Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E57-64. PubMed ID: 19751403
[TBL] [Abstract][Full Text] [Related]
5. Ribavirin can be mutagenic for arenaviruses.
Moreno H; Gallego I; Sevilla N; de la Torre JC; Domingo E; Martín V
J Virol; 2011 Jul; 85(14):7246-55. PubMed ID: 21561907
[TBL] [Abstract][Full Text] [Related]
6. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
Miranda PO; Cubitt B; Jacob NT; Janda KD; de la Torre JC
ACS Infect Dis; 2018 May; 4(5):815-824. PubMed ID: 29405696
[TBL] [Abstract][Full Text] [Related]
7. Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses.
Rojek JM; Pasqual G; Sanchez AB; Nguyen NT; de la Torre JC; Kunz S
J Virol; 2010 Jan; 84(1):573-84. PubMed ID: 19846507
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.
Ortiz-Riaño E; Ngo N; Devito S; Eggink D; Munger J; Shaw ML; de la Torre JC; Martínez-Sobrido L
J Virol; 2014 Jan; 88(2):878-89. PubMed ID: 24198417
[TBL] [Abstract][Full Text] [Related]
9. Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment.
Perales C; Agudo R; Domingo E
PLoS One; 2009; 4(5):e5554. PubMed ID: 19436746
[TBL] [Abstract][Full Text] [Related]
10. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.
Neuman BW; Bederka LH; Stein DA; Ting JP; Moulton HM; Buchmeier MJ
Antimicrob Agents Chemother; 2011 Oct; 55(10):4631-8. PubMed ID: 21825302
[TBL] [Abstract][Full Text] [Related]
11. Reverse genetics approaches to combat pathogenic arenaviruses.
de la Torre JC
Antiviral Res; 2008 Dec; 80(3):239-50. PubMed ID: 18782590
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid.
Vázquez-Calvo Á; Martín-Acebes MA; Sáiz JC; Ngo N; Sobrino F; de la Torre JC
Antiviral Res; 2013 Aug; 99(2):172-9. PubMed ID: 23735299
[TBL] [Abstract][Full Text] [Related]
13. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
Ngo N; Henthorn KS; Cisneros MI; Cubitt B; Iwasaki M; de la Torre JC; Lama J
J Virol; 2015 Nov; 89(21):10924-33. PubMed ID: 26292327
[TBL] [Abstract][Full Text] [Related]
14. Arenavirus Quasispecies and Their Biological Implications.
Grande-Pérez A; Martin V; Moreno H; de la Torre JC
Curr Top Microbiol Immunol; 2016; 392():231-76. PubMed ID: 26472215
[TBL] [Abstract][Full Text] [Related]
15. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
Cheng BY; Ortiz-Riaño E; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Jul; 89(14):7373-84. PubMed ID: 25972555
[TBL] [Abstract][Full Text] [Related]
16. Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections.
Perales C; Agudo R; Tejero H; Manrubia SC; Domingo E
PLoS Pathog; 2009 Nov; 5(11):e1000658. PubMed ID: 19911056
[TBL] [Abstract][Full Text] [Related]
17. Novel antiviral strategies to combat human Arenavirus infections.
Kunz S; de la Torre JC
Curr Mol Med; 2005 Dec; 5(8):735-51. PubMed ID: 16375709
[TBL] [Abstract][Full Text] [Related]
18. No evidence of selection for mutational robustness during lethal mutagenesis of lymphocytic choriomeningitis virus.
Martín V; Grande-Pérez A; Domingo E
Virology; 2008 Aug; 378(1):185-92. PubMed ID: 18572218
[TBL] [Abstract][Full Text] [Related]
19. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
[TBL] [Abstract][Full Text] [Related]
20. The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses.
Iwasaki M; Cubitt B; Sullivan BM; de la Torre JC
J Virol; 2016 Jan; 90(6):3187-97. PubMed ID: 26739049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
